Cresco Labs Inc.
CL
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 163.26M | 174.42M | 178.46M | 181.18M | 181.71M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 163.26M | 174.42M | 178.46M | 181.18M | 181.71M |
| Cost of Revenue | 87.13M | 91.88M | 86.35M | 89.58M | 92.08M |
| Gross Profit | 76.14M | 82.54M | 92.11M | 91.60M | 89.62M |
| SG&A Expenses | 57.39M | 55.33M | 57.75M | 53.51M | 55.04M |
| Depreciation & Amortization | 5.16M | 5.46M | 5.70M | 5.19M | 5.42M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 149.67M | 152.67M | 149.79M | 148.28M | 152.54M |
| Operating Income | 13.59M | 21.75M | 28.66M | 32.90M | 29.16M |
| Income Before Tax | -918.00K | 3.06M | 11.32M | -40.94M | 15.95M |
| Income Tax Expenses | 14.32M | 2.62M | 19.02M | 10.24M | 18.00M |
| Earnings from Continuing Operations | -15.23M | 439.00K | -7.69M | -51.18M | -2.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 802.00K | -4.81M | -2.85M | -3.15M | -3.14M |
| Net Income | -14.43M | -4.37M | -10.54M | -54.33M | -5.19M |
| EBIT | 13.59M | 21.75M | 28.66M | 32.90M | 29.16M |
| EBITDA | 26.50M | 35.65M | 43.59M | 47.83M | 44.49M |
| EPS Basic | -0.04 | -0.01 | -0.03 | -0.16 | -0.02 |
| Normalized Basic EPS | 0.00 | -0.01 | 0.02 | -0.08 | 0.02 |
| EPS Diluted | -0.04 | -0.01 | -0.03 | -0.16 | -0.02 |
| Normalized Diluted EPS | 0.00 | -0.01 | 0.02 | -0.08 | 0.02 |
| Average Basic Shares Outstanding | 350.24M | 347.94M | 347.36M | 344.93M | 341.63M |
| Average Diluted Shares Outstanding | 350.24M | 347.94M | 347.36M | 344.93M | 341.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -1.90% | -- | -- |